Supernus Pharm
(SUPN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 151,371 | 144,711 | 115,848 | 69,331 | 31,673 |
| Marketable Securities | 129,789 | 377,885 | 347,742 | 384,281 | 371,537 |
| Receivables | 171,254 | 140,831 | 145,640 | 142,077 | 145,408 |
| Inventories | 79,399 | 44,023 | 49,423 | 54,293 | 63,981 |
| TOTAL | $593,891 | $738,866 | $687,584 | $686,070 | $640,003 |
| Non-Current Assets | |||||
| PPE Net | 10,627 | 11,069 | 11,338 | 11,545 | 11,876 |
| Intangibles | 742,561 | 598,326 | 619,145 | 638,931 | 657,175 |
| Other Non-Current Assets | 72,675 | 34,144 | 29,223 | 31,527 | 33,647 |
| TOTAL | $825,863 | $643,539 | $659,706 | $682,003 | $702,698 |
| Total Assets | $1,419,754 | $1,382,405 | $1,347,290 | $1,368,073 | $1,342,701 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 108,613 | 77,739 | 76,891 | 76,352 | 75,803 |
| Accrued Expenses | 184,459 | 180,916 | 170,133 | 168,705 | 169,124 |
| Other current liabilities | 37,557 | 27,705 | 34,748 | 47,340 | 46,581 |
| TOTAL | $330,629 | $286,360 | $281,772 | $292,397 | $291,508 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 39,458 | 32,145 | 33,832 | 34,982 | 36,679 |
| TOTAL | $39,458 | $32,145 | $34,813 | $39,943 | $44,043 |
| Total Liabilities | $370,087 | $318,505 | $316,585 | $332,340 | $335,551 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,339 | 56,073 | 55,990 | 55,815 | 55,219 |
| Common Shares | 57 | 56 | 56 | 56 | 55 |
| Retained earnings | 521,981 | 567,098 | 544,599 | 556,426 | 541,098 |
| Other shareholders' equity | -71 | -200 | -159 | -189 | 78 |
| TOTAL | $1,049,667 | $1,063,900 | $1,030,705 | $1,035,733 | $1,007,150 |
| Total Liabilities And Equity | $1,419,754 | $1,382,405 | $1,347,290 | $1,368,073 | $1,342,701 |